Related Experiment Video
Updated: Apr 25, 2026

06:26
Novel and Innovative Hybrid Technique for Type A Aortic Dissection
Published on: March 28, 2025
1.3K
Open surgical repair for chronic type B aortic dissection: a systematic review
David H Tian1, Ramesh P De Silva1, Tom Wang1
11 The Collaborative Research (CORE) Group, Macquarie University, Sydney, Australia ; 2 Department of Cardiothoracic Surgery, Royal Prince Alfred Hospital, Sydney, Australia.
Annals of Cardiothoracic Surgery
|August 19, 2014
Summary
Open surgical repair (OSR) for chronic type B aortic dissection shows acceptable contemporary results. Careful consideration of short- and long-term outcomes is needed when choosing between OSR and thoracic endovascular aortic repair (TEVAR).
Area of Science:
- Cardiovascular Surgery
- Vascular Surgery
- Thoracic Surgery
Background:
- Chronic type B aortic dissection (CBAD) treatment is complex.
- Thoracic endovascular aortic repair (TEVAR) is now preferred over open surgical repair (OSR) for CBAD.
- Long-term outcomes of TEVAR are less understood than OSR, prompting a review of modern OSR techniques.
Purpose of the Study:
- To systematically review and assess the short- and long-term outcomes of OSR for CBAD.
- To compare outcomes between historic and contemporary OSR series.
- To evaluate OSR as a potential alternative to TEVAR for CBAD.
Main Methods:
- Systematic review of six databases from inception to March 2014.
- Included studies focused on OSR for chronic type B dissection.
- Studies were categorized into pre-endovascular (historic) and endovascular (contemporary) eras based on the year 1999.
Main Results:
- Nineteen studies were analyzed; pooled short-term mortality was 11.1% overall and 7.5% in contemporary series.
- Contemporary OSR showed complication rates including stroke (5.9%), spinal cord ischemia (4.9%), renal dysfunction (8.1%), and reoperation for bleeding (8.1%).
- Late reintervention occurred in 13.3% overall and 11.3% in contemporary series, with survival rates at 1, 3, 5, and 10 years at 82.1%, 74.1%, 66.3%, and 50.8% respectively.
Conclusions:
- Contemporary OSR for CBAD yields acceptable results.
- Management decisions require careful consideration of both short- and long-term complications.
- Further research is needed to define optimal indications for OSR versus TEVAR in CBAD.
